The neonatal outcomes of Dexamethasone administration before scheduled cesarean delivery at term: A randomized clinical trial

The neonatal outcomes of Dexamethasone administration before scheduled cesarean delivery at term: A randomized clinical trial - The neonatal outcomes of Dexamethasone administration before scheduled cesarean delivery at term: A randomized clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029070

Enrollment

400

Registered

2018-05-01

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recruiting

Interventions

Receive dexamethasone 8mg IM/12 hours for 3 doses with the last dose at least 24 hours before elective cs Receive saline 0.9% 2ml IM/12 hours for 4 doses with the last dose at least 24 hours before e

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Age 20-40years elective cs full term baby>=37weeks

Exclusion criteria

Exclusion criteria: selective CS malformed baby immature bay refusal to participate

Design outcomes

Primary

Measure	Time frame
neonatal outcomes: Occurrence of RDS, TTN or other respiratory morbidities and the need for incubation or NICU	—

Secondary

Measure	Time frame
Maternal outcome: Wound healing	—

Countries

Africa

Contacts

Public ContactAyman Dawood

Tanta university Marwa saad

ayman.dawood@med.tanta.edu.eg00201010477601

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026